Biomolecular Advances in Diabetes Prevention
https://reachmd.com/programs/focus-on-diabetes/biomolecular-advances-in-diabetes-prevention/6098/
As the epidemic of type 2 diabetes in the United States grows, researchers are investigating hundreds of ways to treat and cure diabetes. Some of these methods include exogenous insulin, while other ideas being explored require more complex changes in our understanding of cellular biology. Dr. Carme
Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
https://reachmd.com/programs/neurofrontiers/visionary-insights-assessing-ms-related-retinal-changes-with-adaptive-optics/18042/
Find out how using adaptive optics can help us study MS-related changes in the retina at a cellular level.
Treating & Preventing Pediatric Overuse Injuries
https://reachmd.com/programs/clinicians-roundtable/treating-preventing-pediatric-overuse-injuries/3275/
More and more children are presenting with overuse injuries. What is happening at the cellular level and how do their bodies repair? Dr. Paul Stricker, board certified in both pediatrics and sports medicine joins host Dr. Bill Rutenberg to discuss pediatric overuse injuries. They discuss the need fo
Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
https://reachmd.com/programs/project-oncology/study-shows-importance-of-comprehensive-genomic-profiling-for-nsclc/15463/
What do we need to know about comprehensive genomic profiling and CGP-directed therapies for NSCLC patients?
Reacting to RET Inhibitors: A Look at Progression & the Future
https://reachmd.com/programs/project-oncology/reacting-to-ret-inhibitors-a-look-at-progression-the-future/12429/
One starting on a RET inhibitor, what do patients need to know about treatment progression into the future?
Getting to Know GRADE: A Comparative Study of T2D Treatment
https://reachmd.com/programs/diabetes-discourse/getting-to-know-grade-a-comparative-study-of-t2d-treatment/14216/
An ancillary study from the landmark GRADE study explores the efficacy of different treatments for type 2 diabetes. What do we need to know about them?
Neuromuscular Disease and Inherited Heart Diseases
https://reachmd.com/programs/clinicians-roundtable/neuromuscular-disease-and-inherited-heart-diseases/2524/
How do inherited heart diseases impact neuromuscular diseases? Dr. Elizabeth McNally, cardiologist and world-renowned expert on heart disease genetics speaks with Dr. Bruce Bloom on inherited heart diseases and their impact on muscular dystrophies; discussing current treatments and the role of cel
Type I diabetes - How close are we to a cure?
https://reachmd.com/programs/clinicians-roundtable/type-i-diabetes-how-close-are-we-to-a-cure/1020/
Dr. Raghu Mirmira, Associate Professor of Medicine and Associate Director of the Diabetes and Hormone Center of Excellence at the University of Virginia School of Medicine in Charlottesville, VA is here to discuss his work with transcription factors, the timing of their expression, the genes they ta
TROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use
https://reachmd.com/programs/cme/trop2-adcs-for-metastatic-nsclc-setting-the-stage-for-future-use/14416/
Are you as excited as we are to see how TROP2-targeted antibody-drug conjugates can help our patients?
Expert Answers to Common Questions for Tailoring ADC Therapies Across the HER2 Spectrum in Metastatic Breast Cancer
https://reachmd.com/programs/cme/expert-answers-to-common-questions-for-tailoring-adc-therapies-across-the-her2-spectrum-in-metastatic-breast-cancer/15658/
HER2 is a well-established negative prognostic factor for metastatic breast cancer (mBC) and determining HER2 levels is essential for proper treatment decisions. Several studies have reported scoring inaccuracies for HER2 status, particularly in